In conclusion, the effects of GLP-1Ra (i.e., semaglutide and liraglutide), including weight loss, slight BMD loss, and increased CTX, resembled to those observed with calorie restriction interventions [7, 9]
8 But the list of conditions that can be treated with GLP-1 medications is expanding, as the drugs have been found to improve outcomes for patients with cardiovascular disease, kidney disease, liver disease, sleep apnea, and various other disorders, as well as their efficacy in helping people lose weight
Victoza may help to both lower or increase leptin depending on the person
If you are ready to take a medically guided approach to peptide therapy, contact Formation at (813) 922-2920 or visit our site to schedule your consultation